Piper Sandler analyst Korinne Wolfmeyer lowered the firm’s price target on Amyris to $2 from $2.50 and keeps a Neutral rating on the shares. The analyst views view China, travel retail, and trade down as key themes to watch in 2023 for the beauty and wellness sector.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMRS: